A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer-Reference-Cited by-同舟云学术

A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer

Published:2006-08 Issue:2 Volume:53 Page:189-195
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Shibayama Takuo,Hotta Katsuyuki,Takigawa Nagio,Tada Atsuhiko,Ueoka Hiroshi,Harita Shingo,Kiura Katsuyuki,Tabata Masahiro,Segawa Yoshihiko,Nogami Naoyuki,Kuyama Shoichi,Shinkai Tetsu,Tanimoto Mitsune

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer;Noda;N Engl J Med,2002

2. Long-term survival and toxicity in small cell lung cancer. Southwest Oncology Group study;Livingston;Am J Med,1984

3. Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up;Johnson;Ann Intern Med,1985

4. Small cell lung cancer;Ihde,1997

5. Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base;Albain;Cancer,1993

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy advances in small-cell lung cancer;J THORAC DIS;2013

2. Amrubicin, a Completely Synthetic 9-Aminoanthracycline for Extensive-Disease Small-Cell Lung Cancer;Case Studies in Modern Drug Discovery and Development;2012-05-21

3. Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402;Acta Oncologica;2012-01-27

4. Risk Factors for Predicting Severe Neutropenia Induced by Amrubicin in Patients with Advanced Lung Cancer;Chemotherapy;2012

5. A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401;Lung Cancer;2011-02